Cardiovascular autonomic dysfunction, depression and cognitive disorders in Parkinson’s disease patients
Objective: The aim of the study was to determine the relationship between depression, cognitive disorders and autonomic regulation of the cardiovascular system in patients with…Parkinson Disease-Associated Polyneuropathy: A Biomarker of Disease Severity?
Objective: Objective: We sought to examine the association between Parkinson disease (PD) associated polyneuropathy (PD-PNP) and levodopa dose, age, and disease duration in a cross-sectional,…Profiling the Non Motor Symptoms burden in Parkinson’s disease patients in Nigeria
Objective: To determine the frequency of Non- motor symptoms (NMS) burden using the non-motor symptoms questionnaire (NMSQuest). Background: Over the years, motor manifestations were more associated with…Olfaction and gustation in patients with Parkinson’s Disease
Objective: This study investigates smell and taste function in patients with Parkinson’s Disease (PD). Background: Up to 90% of patients with PD suffer from olfactory…A global survey of the use and linguistic translation of the NMSQuest and NMSScale: implications for non-motor studies in Parkinson’s disease
Objective: To collect details of linguistic validations and translations of the non-motor symptoms questionnaire (NMSQuest) and non-motor symptoms scale (NMSScale) globally. Background: The patient completed…Weight loss in Parkinson’s disease (PD)
Objective: To quantify and assess weight loss in older patients with PD attending a Movement disorders clinic Background: Patients with Parkinson’s disease often lose weight…Videoendoscopy study of swallowing in Parkinson’s disease
Objective: We make a hypothesis that dysphagia of anti-parkinsonian drugs may be associated with motor fluctuation, especially delay on. In this study, we compared videoendoscopy…Speech Markers Estimate Motor Severity and Global Cognition in Parkinson’s Disease
Objective: To utilize free speech characteristics to develop markers of motor and cognitive status in Parkinson’s disease (PD). Background: Vocal biomarkers based on speech volume,…Impulse control disorder and associated clinical factors in drug-naïve Parkinson’s disease.
Objective: To investigate various clinical factors associated with Impulse Control Disorders (ICD) in Parkinson's disease (PD) patients who have never been exposed to Dopamine Replacement…Relationship between sleep profiles and clinical features in Parkinson’s disease
Objective: To document the prevalence of sleep disturbance and excessive daytime sleepiness (EDS) in Taiwanese Parkinson’s disease (PD) patients and to identify the risk factors…
